Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Direxion Daily CSI China Internet Bull 2X Shares (CWEB) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

Direxion Daily CSI China Internet Bull 2X SharesTrade
DENTSPLY SIRONA IncTrade

Price performance (Past 24H)

Key statistics

Direxion Daily CSI China Internet Bull 2X Shares vs DENTSPLY SIRONA Inc — how do they compare? Direxion Daily CSI China Internet Bull 2X Shares trades at $18.91 (market cap $173.62M), while DENTSPLY SIRONA Inc trades at $8.83 (market cap $1.73B). The key difference: DENTSPLY SIRONA Inc is far larger — about 10× Direxion Daily CSI China Internet Bull 2X Shares's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Direxion Daily CSI China Internet Bull 2X Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Direxion Daily CSI China Internet Bull 2X Shares for 24 Days and DENTSPLY SIRONA Inc for 72 Days on average.

CWEBXRAY
Market Cap
$173.62M$1.73B
Volume
551,7266,198,582
Sector
Leveraged / InverseHealth
52-Week High
$55.62$14.68
52-Week Low
$17.39$8.52
Typical Hold Time
24 Days72 Days
Enterprise Value
—$3.80B
Dividend Yield
—5.04%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Direxion Daily CSI China Internet Bull 2X Shares

CWEB trades at $18.91, up 4.94% today, but technical indicators show a bearish trend with moving averages and ADX signaling sell conditions. The stock faces resistance at $18 with support at $17. Recent news highlights China's AI sector growth potential as a catalyst for CWEB's performance.

Outlook remains cautious due to bearish technicals, though exposure to China's AI and semiconductor sectors offers growth opportunities. Key risks include geopolitical tensions and market volatility. Investors should monitor earnings reports for fundamental validation of current valuation levels.

DENTSPLY SIRONA Inc

DENTSPLY SIRONA (XRAY) trades at $8.83, down 3.4% with bearish technical signals. The stock faces fundamental challenges with negative net income margins (-14.99%) and declining revenue trends ($3.68B in 2025). Recent Q2 2026 earnings beat expectations but sales fell 4.1% amid ongoing turnaround efforts. The company maintains strong institutional interest despite hitting 52-week lows in September 2026.

XRAY presents a high-risk opportunity with Wall Street maintaining a cautious stance (37.5% buy rating). The consensus price target of $13.40 offers 52% upside potential, but investors face execution risks in the dental equipment turnaround, margin pressures, and competitive challenges. Near-term catalysts include management's presentation at the Baird Healthcare Conference in September 2026.

Returns comparison

Trailing returns across standard periods

About Direxion Daily CSI China Internet Bull 2X Shares

CWEB is a leveraged ETF that seeks to provide two times (2x) the daily performance of the CSI China Internet Index. It offers magnified exposure to top Chinese internet companies listed on US and Hong Kong exchanges.

Read more on CWEB →

About DENTSPLY SIRONA Inc

Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters

Read more on XRAY →